CY2011004I2 - Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων - Google Patents

Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων

Info

Publication number: CY2011004I2
Authority: CY; Cyprus
Prior art keywords: chimeral; circular dna; dna clones; pig circular; infectious
Prior art date: 2001-12-12

Application number

CY2011004C

Other languages

English (en)

Other versions

CY2011004I1 (el

Original Assignee

Iowa State University Research Foundation, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-12

Filing date

2011-05-06

Publication date

2015-10-07

2011-05-06 Application filed by Iowa State University Research Foundation, Inc. filed Critical Iowa State University Research Foundation, Inc.

2014-04-09 Publication of CY2011004I1 publication Critical patent/CY2011004I1/el

2015-10-07 Publication of CY2011004I2 publication Critical patent/CY2011004I2/el

Links

108020004638 Circular DNA Proteins 0.000 title 1
208000015181 infectious disease Diseases 0.000 title 1
230000002458 infectious effect Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10061—Methods of inactivation or attenuation

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Pharmacology & Pharmacy (AREA)
General Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Microbiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biophysics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

CY2011004C 2001-12-12 2011-05-06 Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων CY2011004I2 (el)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US34077501P	2001-12-12	2001-12-12
US42484002P	2002-11-08	2002-11-08
US10/314,512 US7276353B2 (en)	2001-12-12	2002-12-09	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
PCT/US2002/039646 WO2003049703A2 (en)	2001-12-12	2002-12-11	Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof

Publications (2)

Publication Number	Publication Date
CY2011004I1 CY2011004I1 (el)	2014-04-09
CY2011004I2 true CY2011004I2 (el)	2015-10-07

Family

ID=27405726

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
CY20111100127T CY1111167T1 (el)	2001-12-12	2011-02-03	Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων
CY2011004C CY2011004I2 (el)	2001-12-12	2011-05-06	Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων
CY181101151T CY1121112T1 (el)	2001-12-12	2018-11-05	Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
CY20111100127T CY1111167T1 (el)	2001-12-12	2011-02-03	Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
CY181101151T CY1121112T1 (el)	2001-12-12	2018-11-05	Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων

Country Status (30)

Country	Link
US (1)	US7276353B2 (el)
EP (5)	EP3388515A1 (el)
JP (1)	JP4623964B2 (el)
KR (1)	KR101014544B1 (el)
CN (2)	CN103536911B (el)
AT (1)	ATE487490T1 (el)
AU (3)	AU2002362147C1 (el)
BE (1)	BE2011C008I2 (el)
BR (1)	BRPI0214919B1 (el)
CA (2)	CA2469599C (el)
CO (1)	CO5590938A2 (el)
CY (3)	CY1111167T1 (el)
DE (2)	DE60238278D1 (el)
DK (3)	DK2264050T3 (el)
ES (3)	ES2355814T3 (el)
FR (1)	FR11C0014I2 (el)
HR (3)	HRP20140002B1 (el)
HU (5)	HU231162B1 (el)
LT (1)	LT2264050T (el)
LU (1)	LU91814I2 (el)
ME (1)	ME00126B (el)
MX (1)	MXPA04005364A (el)
NL (1)	NL300480I2 (el)
NZ (2)	NZ567688A (el)
PL (3)	PL395510A1 (el)
PT (3)	PT1487483E (el)
RS (1)	RS51288B (el)
SI (3)	SI2264050T1 (el)
TW (1)	TWI314580B (el)
WO (1)	WO2003049703A2 (el)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2772047B1 (fr) *	1997-12-05	2004-04-09	Ct Nat D Etudes Veterinaires E	Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US7279166B2 (en) *	2001-12-12	2007-10-09	Virginia Tech Intellectual Properties, Inc.	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
CN1749397B (zh) *	2004-08-18	2010-12-08	金宁一	共表达猪圆环病毒及口蹄疫病毒的二联重组活载体疫苗
US7700285B1 (en)	2005-12-29	2010-04-20	Boehringer Ingelheim Vetmedica, Inc.	PCV2 immunogenic compositions and methods of producing such compositions
UA95602C2 (ru)	2004-12-30	2011-08-25	Берингер Ингельхейм Ветмедика, Инк.	Иммуногенная композиция цвс2 и способы приготовления такой композиции
US7833707B2 (en)	2004-12-30	2010-11-16	Boehringer Ingelheim Vetmedica, Inc.	Methods of overexpression and recovery of porcine circovirus type 2 ORF2
RU2620968C9 (ru)	2004-12-30	2017-08-08	Берингер Ингельгейм Ветмедика, Инк.	Иммуногенные композиции pcv2 и способы получения таких композиций
US8834891B2 (en)	2005-03-14	2014-09-16	Boehringer Ingelheim Vetmedica, Inc.	Immunogenic compositions comprising Lawsonia intracellularis
CN1328373C (zh) *	2005-04-07	2007-07-25	南京农业大学	猪ⅱ型圆环病毒重组腺病毒
EP1896069B1 (en) *	2005-06-24	2013-03-13	Intervet International BV	Inactivated chimeric vaccines and related methods of use
CN101277717A (zh)	2005-09-09	2008-10-01	英特威国际有限公司	Pcv-2疫苗
CA2635430A1 (en) *	2005-12-29	2007-08-23	Boehringer Ingelheim Vetmedica, Inc.	Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs
DK2275132T3 (da)	2005-12-29	2021-05-17	Boehringer Ingelheim Animal Health Usa Inc	Multivalente pcv2-immunogeniske sammensætninger og fremgangsmåder til at fremstille dem
JP4625485B2 (ja) *	2006-09-29	2011-02-02	財団法人大阪産業振興機構	高病原性トリインフルエンザウイルスに対するモノクローナル抗体
WO2008064299A2 (en) *	2006-11-22	2008-05-29	Boehringer Ingelheim Vetmedica, Inc.	Methods of reducing porcine circovirus-associated disease outbreaks
WO2008073464A2 (en)	2006-12-11	2008-06-19	Boehringer Ingelheim Vetmedica, Inc.	Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
PT2094872T (pt)	2006-12-15	2017-04-27	Boehringer Ingelheim Vetmedica Inc	Tratamento de porcos seropositivos para o anticorpo anti-pcv2 com antigénio de pcv2
EP1941903A1 (en) *	2007-01-03	2008-07-09	Boehringer Ingelheim Vetmedica Gmbh	Prophylaxis and treatment of PRDC
EP1958644A1 (en)	2007-02-13	2008-08-20	Boehringer Ingelheim Vetmedica Gmbh	Prevention and treatment of sub-clinical pcvd
AU2008294036A1 (en) *	2007-05-30	2009-03-05	Wyeth Llc	Raccoon poxvirus expressing genes of porcine virus
US20090017064A1 (en) *	2007-07-10	2009-01-15	Wyeth	Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
US7829274B2 (en) *	2007-09-04	2010-11-09	Boehringer Ingelheim Vetmedica, Inc.	Reduction of concomitant infections in pigs by the use of PCV2 antigen
US9056909B2 (en) *	2007-11-06	2015-06-16	Zoetis Services Llc	Mycoplasma hyopneumoniae avirulent adjuvanted live vaccine
CA2710247C (en) *	2007-12-21	2014-02-18	Wyeth Llc	Methods and compositions for immunizing pigs against porcine circovirus
CN101932336B (zh) *	2007-12-31	2014-07-09	贝林格尔.英格海姆维特梅迪卡有限公司	有外来氨基酸插入的pcv2 orf2病毒样颗粒
KR20100113582A (ko)	2008-01-23	2010-10-21	베링거잉겔하임베트메디카인코퍼레이티드	Ｐｃｖ2 마이코플라즈마 히오뉴모니에 면역원성 조성물 및 당해 조성물의 생산 방법
EP2254595A4 (en) *	2008-02-15	2012-12-05	Boehringer Ingelheim Vetmed	METHODS AND COMPOSITIONS FOR REDUCING THE IMPACT OF ENTERIC DISEASES
KR20100135903A (ko) *	2008-04-16	2010-12-27	버지니아 테크 인터렉추얼 프라퍼티스, 인크.	키메라 돼지 써코바이러스 ＰＣＶ２Ｇｅｎ―１Ｒｅｐ 및 이의 용도
TWI627281B (zh)	2009-09-02	2018-06-21	百靈佳殷格翰家畜藥品公司	降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
HUE047972T2 (hu)	2010-03-16	2020-05-28	Virginia Tech Intellectual Properties Inc	Gyengített, élõ kiméra sertés cirkovírus vakcina
TWI508974B (zh)	2010-12-22	2015-11-21	Sbc Virbac Ltd	豬第二型環狀病毒(Porcine Circovirus Type 2)、含彼之免疫組合物、檢測套組及其應用
US20130313127A1 (en)	2010-12-28	2013-11-28	The University Of Tokyo	Organic compound hydrogenation device and hydrogenation method
HUP1100470A2 (en) *	2011-08-30	2013-03-28	Mezoegazdasagi Biotechnologiai Kutatokoezpont	Nanoparticle-based veterinary vaccine
UA113192C2 (xx)	2011-12-06	2016-12-26		Імуногенна композиція проти цирковірусу свиней типу 2 (pcv2)
UA114504C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9120859B2 (en)	2012-04-04	2015-09-01	Zoetis Services Llc	Mycoplasma hyopneumoniae vaccine
UA114503C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv та mycoplasma hyopneumoniae
KR102217387B1 (ko) *	2013-03-11	2021-02-19	주식회사 중앙백신연구소	재조합 효모 전세포(yeast whole cell)을 이용한 돼지 써코바이러스(PCV2) 서브유닛 백신과 그의 제조 방법
CA2925281C (en)	2013-09-25	2022-05-03	Zoetis Services Llc	Pcv2b divergent vaccine composition and methods of use
ES2778425T3 (es)	2013-10-02	2020-08-10	Boehringer Ingelheim Animal Health Usa Inc	Variante de la proteína ORF2 del PCV2 y partículas similares a virus compuestas por esta
CN103602759B (zh) *	2013-11-22	2015-09-23	福建省农业科学院畜牧兽医研究所	一种区别鸭圆环病毒和鹅圆环病毒的pcr-rflp方法
PL3076996T3 (pl)	2013-12-03	2020-05-18	Intervet International B.V.	Szczepionka przeciwko cirkowirusowi świń typu 2
MX2018010796A (es) *	2016-03-07	2019-01-14	Virginia Tech Intellectual Properties Inc	Vacunas de circovirus porcino quimerico tipo 2 (pcv2).
CN106497892A (zh) *	2016-09-07	2017-03-15	扬州大学	带KT3标签的重组病毒rPCV2‑KT3的构建方法
CN119488586A (zh)	2018-03-26	2025-02-21	勃林格殷格翰动物保健美国有限公司	制备免疫原性组合物的方法
CN112898435B (zh) *	2021-01-14	2023-03-31	山西农业大学	一种可溶性融合蛋白DT390-Cap及其制备方法与应用
AR132582A1 (es)	2023-05-03	2025-07-16	Boehringer Ingelheim Vetmedica Gmbh	Método para inducir una respuesta inmunitaria
EP4704977A1 (en)	2023-05-03	2026-03-11	Boehringer Ingelheim Vetmedica GmbH	Immunogenic composition useful for self-administration by pigs
US20250332242A1 (en)	2024-04-30	2025-10-30	Zoetis Services Llc	Porcine endogenous retrovirus (perv)-free porcine circovirus type 2d-based vaccines and methods of use
US20250332243A1 (en)	2024-04-30	2025-10-30	Zoetis Services Llc	Methods of manufacturing porcine endogenous retrovirus (perv) free animal health vaccines
WO2026099754A1 (en)	2024-11-06	2026-05-15	Boehringer Ingelheim Vetmedica Gmbh	Method for reducing virus shedding, tissue colonization, and lymphoid depletion caused by or associated with pcv2 infection

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6517843B1 (en)	1999-08-31	2003-02-11	Merial	Reduction of porcine circovirus-2 viral load with inactivated PCV-2
US6391314B1 (en) *	1997-10-03	2002-05-21	Merial	Porcine circoviruses vaccines diagnostic reagents
FR2769321B1 (fr)	1997-10-03	2001-10-26	Merial Sas	Nouveaux circovirus porcins, vaccins et reactifs de diagnostics
FR2781159B1 (fr)	1998-07-06	2000-10-06	Merial Sas	Vaccin circovirus et parvovirus porcin
UA78180C2 (uk) *	1997-10-03	2007-03-15	Меріаль	Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
FR2769322B1 (fr)	1997-10-03	2002-03-08	Merial Sas	Nouveaux circovirus porcins, vaccins et reactifs de diagnostic
FR2772047B1 (fr)	1997-12-05	2004-04-09	Ct Nat D Etudes Veterinaires E	Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
JP3795751B2 (ja) *	1997-12-11	2006-07-12	ユニバーシティオブサスカッチェワン	ブタからの離乳後多全身系消耗症候群ウイルス
WO1999045956A1 (en)	1998-03-13	1999-09-16	University Of Georgia Research Foundation, Inc.	Vaccines against circovirus infections
US6497883B1 (en) *	1999-06-10	2002-12-24	Merial	Porcine circovirus recombinant poxvirus vaccine
US6943152B1 (en)	1999-06-10	2005-09-13	Merial	DNA vaccine-PCV
WO2001083737A2 (en)	2000-05-03	2001-11-08	University Of Guelph	Porcine adenovirus type 5 vector and vaccine
JP2003533989A (ja) *	2000-05-24	2003-11-18	メリアル	ブタ生殖・呼吸症候群ウィルス（ｐｒｒｓｖ）の組換えポックスウィルスワクチン
WO2001096377A2 (en)	2000-06-15	2001-12-20	Purdue Research Foundation	Vaccine for congenital tremors in pigs
DE10044648A1 (de) *	2000-09-08	2002-03-21	Aventis Behring Gmbh	Verfahren zur Vermehrung oder zur Entfernung von Cirocoviren aus biologischem Material
MY146518A (en) *	2001-03-27	2012-08-15	Univ Saskatchewan	Methods to culture circovirus.
AUPR567401A0 (en)	2001-06-14	2001-07-12	University Of Melbourne, The	Circovirus vaccines

2002
- 2002-12-09 US US10/314,512 patent/US7276353B2/en not_active Expired - Lifetime
- 2002-12-11 CN CN201210306454.2A patent/CN103536911B/zh not_active Expired - Lifetime
- 2002-12-11 RS YUP-517/04A patent/RS51288B/sr unknown
- 2002-12-11 HR HRP20140002AA patent/HRP20140002B1/hr not_active IP Right Cessation
- 2002-12-11 CA CA2469599A patent/CA2469599C/en not_active Expired - Lifetime
- 2002-12-11 PT PT02797280T patent/PT1487483E/pt unknown
- 2002-12-11 PL PL395510A patent/PL395510A1/pl not_active Application Discontinuation
- 2002-12-11 HR HRP20040626AA patent/HRP20040626B9/hr not_active IP Right Cessation
- 2002-12-11 DK DK10184702.8T patent/DK2264050T3/en active
- 2002-12-11 SI SI200231091T patent/SI2264050T1/sl unknown
- 2002-12-11 EP EP18175133.0A patent/EP3388515A1/en active Pending
- 2002-12-11 DE DE60238278T patent/DE60238278D1/de not_active Expired - Lifetime
- 2002-12-11 NZ NZ567688A patent/NZ567688A/en not_active IP Right Cessation
- 2002-12-11 LT LTEP10184702.8T patent/LT2264050T/lt unknown
- 2002-12-11 SI SI200231053T patent/SI2263689T1/sl unknown
- 2002-12-11 EP EP10184612.9A patent/EP2263689B1/en not_active Expired - Lifetime
- 2002-12-11 PT PT10184702T patent/PT2264050T/pt unknown
- 2002-12-11 PL PL395509A patent/PL215058B1/pl unknown
- 2002-12-11 JP JP2003550754A patent/JP4623964B2/ja not_active Expired - Lifetime
- 2002-12-11 MX MXPA04005364A patent/MXPA04005364A/es active IP Right Grant
- 2002-12-11 AU AU2002362147A patent/AU2002362147C1/en not_active Expired
- 2002-12-11 HU HU1800263A patent/HU231162B1/hu active Protection Beyond IP Right Term
- 2002-12-11 PL PL374382A patent/PL214803B1/pl not_active IP Right Cessation
- 2002-12-11 HU HU0501000A patent/HU228584B1/hu active Protection Beyond IP Right Term
- 2002-12-11 HR HRP20140003AA patent/HRP20140003B1/hr not_active IP Right Cessation
- 2002-12-11 EP EP10184771A patent/EP2263690A3/en not_active Withdrawn
- 2002-12-11 CN CN02828049.0A patent/CN1620310B/zh not_active Expired - Lifetime
- 2002-12-11 ES ES02797280T patent/ES2355814T3/es not_active Expired - Lifetime
- 2002-12-11 ES ES10184612.9T patent/ES2529726T3/es not_active Expired - Lifetime
- 2002-12-11 HU HU1600373A patent/HU231018B1/hu unknown
- 2002-12-11 NZ NZ533256A patent/NZ533256A/en not_active IP Right Cessation
- 2002-12-11 AT AT02797280T patent/ATE487490T1/de active
- 2002-12-11 PT PT101846129T patent/PT2263689E/pt unknown
- 2002-12-11 ME MEP-2008-177A patent/ME00126B/me unknown
- 2002-12-11 DK DK02797280.1T patent/DK1487483T3/da active
- 2002-12-11 HU HU1300097A patent/HU230576B1/hu unknown
- 2002-12-11 DE DE201112100001 patent/DE122011100001I1/de active Pending
- 2002-12-11 ES ES10184702.8T patent/ES2694505T3/es not_active Expired - Lifetime
- 2002-12-11 BR BRPI0214919A patent/BRPI0214919B1/pt not_active IP Right Cessation
- 2002-12-11 SI SI200230932T patent/SI1487483T1/sl unknown
- 2002-12-11 KR KR1020047009126A patent/KR101014544B1/ko not_active Expired - Lifetime
- 2002-12-11 WO PCT/US2002/039646 patent/WO2003049703A2/en not_active Ceased
- 2002-12-11 EP EP02797280A patent/EP1487483B1/en not_active Expired - Lifetime
- 2002-12-11 EP EP10184702.8A patent/EP2264050B1/en not_active Expired - Lifetime
- 2002-12-11 CA CA2784260A patent/CA2784260C/en not_active Expired - Lifetime
- 2002-12-11 DK DK10184612.9T patent/DK2263689T3/en active
- 2002-12-12 TW TW091135955A patent/TWI314580B/zh not_active IP Right Cessation
2004
- 2004-06-10 CO CO04054666A patent/CO5590938A2/es unknown
2008
- 2008-05-27 AU AU2008202333A patent/AU2008202333B2/en not_active Expired
2011
- 2011-02-03 CY CY20111100127T patent/CY1111167T1/el unknown
- 2011-02-25 AU AU2011200843A patent/AU2011200843B2/en not_active Expired
- 2011-04-29 BE BE2011C008C patent/BE2011C008I2/fr unknown
- 2011-05-02 LU LU91814C patent/LU91814I2/fr unknown
- 2011-05-03 FR FR11C0014C patent/FR11C0014I2/fr active Active
- 2011-05-06 CY CY2011004C patent/CY2011004I2/el unknown
- 2011-05-06 NL NL300480C patent/NL300480I2/nl unknown
2018
- 2018-11-05 CY CY181101151T patent/CY1121112T1/el unknown
2021
- 2021-09-14 HU HUS2100036C patent/HUS2100036I1/hu unknown

Also Published As

Publication number	Publication date
ES2694505T3 (es)	2018-12-21
MXPA04005364A (es)	2004-09-27
EP2264050B1 (en)	2018-08-08
CN103536911A (zh)	2014-01-29
PL214803B1 (pl)	2013-09-30
WO2003049703A8 (en)	2005-12-01
DE122011100001I1 (de)	2011-09-08
NZ567688A (en)	2009-09-25
HUP0501000A2 (en)	2007-12-28
TW200307042A (en)	2003-12-01
HRP20040626A2 (en)	2006-03-31
EP1487483B1 (en)	2010-11-10
CA2784260C (en)	2016-05-17
PL395510A1 (pl)	2011-12-19
HUP1300097A2 (en)	2007-12-28
WO2003049703A3 (en)	2004-09-30
FR11C0014I2 (fr)	2022-03-11
KR101014544B1 (ko)	2011-02-16
BE2011C008I2 (el)	2022-02-02
WO2003049703A2 (en)	2003-06-19
EP2263690A3 (en)	2011-06-08
JP2005511075A (ja)	2005-04-28
HU228584B1 (en)	2013-04-29
NZ533256A (en)	2008-06-30
CA2784260A1 (en)	2003-06-19
DK1487483T3 (da)	2011-02-21
EP2263690A2 (en)	2010-12-22
ATE487490T1 (de)	2010-11-15
AU2008202333A1 (en)	2008-06-19
US7276353B2 (en)	2007-10-02
AU2011200843B2 (en)	2012-01-19
PT2264050T (pt)	2018-11-21
SI2264050T1 (sl)	2018-12-31
CN103536911B (zh)	2019-09-13
HRP20140002A2 (hr)	2014-11-07
EP2264050A3 (en)	2011-04-20
CY2011004I1 (el)	2014-04-09
AU2002362147C1 (en)	2012-05-17
CA2469599A1 (en)	2003-06-19
JP4623964B2 (ja)	2011-02-02
RS51288B (sr)	2010-12-31
CA2469599C (en)	2012-10-23
AU2011200843A1 (en)	2011-03-17
HRP20140003A2 (hr)	2014-11-07
HU231018B1 (hu)	2019-11-28
ES2529726T3 (es)	2015-02-25
DK2263689T3 (en)	2015-02-02
EP2263689A2 (en)	2010-12-22
LT2264050T (lt)	2018-11-26
FR11C0014I1 (el)	2011-06-17
RS51704A (sr)	2006-10-27
CY1111167T1 (el)	2014-04-09
MEP17708A (bs)	2010-06-10
DK2264050T3 (en)	2018-12-03
EP2263689A3 (en)	2011-04-20
US20030170270A1 (en)	2003-09-11
EP3388515A1 (en)	2018-10-17
TWI314580B (en)	2009-09-11
HU231162B1 (hu)	2021-05-28
CO5590938A2 (es)	2005-12-30
BR0214919A (pt)	2006-05-30
PL215058B1 (pl)	2013-10-31
CN1620310A (zh)	2005-05-25
AU2008202333B2 (en)	2010-11-25
HU230576B1 (hu)	2017-01-30
NL300480I2 (el)	2016-11-01
HRP20140003B1 (hr)	2020-10-16
HRP20140002B1 (hr)	2020-10-16
PT1487483E (pt)	2011-02-10
BRPI0214919B1 (pt)	2015-09-15
HUS2100036I1 (hu)	2021-09-28
SI1487483T1 (sl)	2011-03-31
HRP20040626B1 (hr)	2016-08-26
AU2002362147B2 (en)	2008-03-13
CN1620310B (zh)	2014-11-26
ME00126B (me)	2010-10-10
HK1151988A1 (en)	2012-02-17
EP1487483A4 (en)	2006-02-15
LU91814I2 (fr)	2011-07-04
PL395509A1 (pl)	2011-12-19
PT2263689E (pt)	2015-02-13
HRP20040626B9 (hr)	2016-09-23
KR20040086243A (ko)	2004-10-08
CY1121112T1 (el)	2019-12-11
DE60238278D1 (de)	2010-12-23
ES2355814T3 (es)	2011-03-31
EP2264050A2 (en)	2010-12-22
EP2263689B1 (en)	2014-11-12
AU2002362147A1 (en)	2003-06-23
PL374382A1 (en)	2005-10-17
EP1487483A2 (en)	2004-12-22
SI2263689T1 (sl)	2015-03-31

Publication	Publication Date	Title
CY2011004I1 (el)	2014-04-09	Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων
DE60238478D1 (de)	2011-01-13	Eren
DE60212600D1 (de)	2006-08-03	Audiocodierung und decodierung
EP1412378A4 (en)	2006-09-20	APTAMERS AND ANTIAPTAMERS
DE50112013D1 (de)	2007-03-22	Deodorantien und antiperspirantien
DE60206625D1 (de)	2005-11-17	Haarkonditionierungsmittel
DK1390389T3 (da)	2009-04-20	Cripto-blokerende antistoffer og anvendelser deraf
EP1298180A4 (en)	2005-03-09	HYDROPHOBIC AND LIPOPHOBE COMPOSITION
DE60223344D1 (de)	2007-12-20	Silicoaluminophosphat-molekularsieb
EP1441129A4 (en)	2010-04-14	TURBO PUMP
DE60216254D1 (de)	2007-01-04	Acrylkautschukzusammensetzung und vulkanisat
DE60204686D1 (de)	2005-07-21	3-arylsubstituierte zyklopentadienyl-metal-komplexe und polymerisationsverfahren
NO20035121D0 (no)	2003-11-17	Ny anvendelse
NO20030239L (no)	2003-03-18	Modifisert virus
NO20022092D0 (no)	2002-05-02	Orienterings- og lokaliseringssystem
DE60208700D1 (de)	2006-04-06	Schälgerät und zugehörige verfahren
DE60223044D1 (de)	2007-11-29	Granulatförmiges herbizid
DE60226693D1 (de)	2008-07-03	Härtbare Mischungen
DE60212612D1 (de)	2006-08-03	Farbige peroxyd- und polyester-formulierungen
DE60203475D1 (de)	2005-05-04	Drosselklappe und Drossel
DE60227607D1 (de)	2008-08-28	Spielsystem und Spielprogramm
NO20033919D0 (no)	2003-09-04	Ny anvendelse
FI20010432A0 (fi)	2001-03-05	Puhallin
DE60207900D1 (de)	2006-01-19	"Suspend"-Paketübertrager
DE60219418T8 (de)	2008-04-30	Silanylphenole und -naphthole